The global mycoplasma testing market is expected to reach a value of USD 1.4 billion by 2025, according to a new report by Grand View Research, Inc. With growing R&D investments in the field of life sciences, the demand for mycoplasma testing products are anticipated to rise in the near future. Huge opportunities in the life sciences segment are spurring the market growth. Hence, a large amount of investment is being made in the biotechnology and pharmaceutical industries with rising level of healthcare spending across the globe. This is expected to trigger high growth of mycoplasma testing market.
Investment in R&D activities by pharmaceutical and biotechnology companies is increasingly being supported by the government. Researches involving drug discovery and development, receive funding from the governmental bodies to a great extent. Moreover, governmental initiatives in the form of awareness campaigns for chronic diseases such as cancer are also encouraging research-based activities. Thus, the aforementioned factors are expected to drive the market growth.
Mycoplasma contamination of cell culture is a growing concern for most of the research scientists for decades. Mycoplasma infection arises majorly from laboratory workers as human mycoplasma contamination occurs at a faster rate. In order to combat further contamination, mycoplasma tests are being conducted, which is expected to increase the demand of the related products.
Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/267649
Further Key Findings From the Study Suggest:
In 2016, kits & reagents dominated the market and is also expected to show highest CAGR over the forecast period owing to its wider application in mycoplasma tests
Amongst the technology segment, Polymerase Chain Reaction (PCR) held the largest share in 2016 owing to the delivery of fast & accurate results associated with this technology
Cell line testing is anticipated to exhibit highest CAGR over the forecast period due to the increasing risk of cell line contamination
In 2016, pharmaceutical and biotechnology companies accounted for the largest market share due to rising number of research activities in drug discovery and development
North America dominated the market in 2016 owing to rising healthcare spending levels and government funding for life science-related research
Some of the key players are Merck KGaA; Sigma-Aldrich Co.; Thermo Fisher Scientific; Lonza Group Ltd.; Charles River Laboratories International, Inc.; PromoCell GmbH; and Bionique Testing Laboratories, Inc.
Buy the report@http://www.orbisresearch.com/contact/purchase/267649
Major Points From Table Of Contents:
Chapter One: Research Methodology
Chapter Two: Executive Summary
Chapter Three: Mycoplasma Testing Market Variables, Trends & Scope
Chapter Four: Mycoplasma Testing: Product Estimates & Trend Analysis
Chapter Five: Mycoplasma Testing: Technology Estimates & Trend Analysis
Chapter Six: Mycoplasma Testing: Application Estimates & Trend Analysis
Chapter Seven: Mycoplasma Testing: End-Use Estimates & Trend Analysis
Chapter Eight: Mycoplasma Testing Market: Regional Estimates & Trend Analysis, by Product, Technology, Application, End-Use
Chapter Nine: Competitive Landscape
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Media Contact
Company Name: Orbis Research
Contact Person: Hector Costello
Email:Send Email
Phone: +1 (214) 884-6817
Address:4144N Central Expressway, Suite 600
City: Dallas
State: Texas
Country: United States
Website: http://www.orbisresearch.com/reports/index/mycoplasma-testing-market-analysis-by-product-by-technology-pcr-elisa-direct-assay-microbial-culture-techniques-by-application-cell-line-virus-and-end-of-production-cells-testing-by-end-use-and-segment-forecasts-2014-2025
